Will GoodRx stock go up?

According to Danelfin AI, GoodRx has today an AI Score of 1/10 (Strong Sell rating), because its probability of beating the market in 3 months (40.17%) is -10.64% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for GoodRx stock?

The GoodRx target price is $3.5 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold GoodRx stock right now?

GoodRx has today a Strong Sell rating (AI Score 1/10), according to Danelfin AI. Its probability of beating the market in 3 months (40.17%) is -10.64% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether GoodRx stock is a good buy .

Is GoodRx undervalued right now?

Based on analysts, the average price target upside for GoodRx is +13.57% (1Y). According to Danelfin AI, GoodRx has today an AI Score of 1/10 (Strong Sell Rating).

What was the price range of GoodRx stock over the past 12 months?

The GoodRx stock price range over the past 12 months has been $1.87 - $5.12.

What is going on with GoodRx stock in the last 3 months?

The GoodRx stock performance in the last quarter has been +57.14%.

Does GoodRx offer dividend payments?

No, GoodRx does not currently pay dividends.

What is the current market capitalization of GoodRx?

GoodRx's market cap is $1.04B, as of 2026-07-02 08:00.

When is the next GDRX earnings report date?

GDRX will publish its next earnings report on 2026-05-06.

GoodRx Holdings Inc (GDRX) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

GDRX AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Earnings Quality+0.26%
Stability and reliability of reported earnings
Volatility+0.26%
How much the stock price tends to fluctuate

Sentiment-7.03%
How analysts and the market view the stock
Momentum-3.41%
Direction and strength of recent price movements
Profitability-0.52%
Profitability and operating efficiency metrics
Valuation-0.20%
How the stock is priced relative to its fundamentals

GDRX probability advantage of beating the market (3M):

-10.64%

AI Score

Strong Sell

GoodRx (GDRX) has an AI Score of 1/10 (Strong Sell) because, according to an overall analysis, it has a probability advantage of -10.64% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of GDRX (40.17%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
GDRX probability advantage of beating the market (3M)-10.64%
GDRX probability of beating the market (3M)40.17%

GDRX probability advantage of beating the market (3M): -10.64%

The AI-powered overall analysis of GoodRx (GDRX) is based on the 26 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of GDRX:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Sentiment	Industry (GICS)	Health Care Technology	N/A	-4.36%
Technical	Chart Pattern (504d)	figure_69	N/A	-2.06%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-1.45%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.89%
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+0.79%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	11.74		-0.74%
Technical	Technicals Impact (Long Tail)	-	N/A	+0.65%
Technical	Chart Pattern (180d)	figure_95	N/A	-0.61%
Sentiment	Analyst Lowest Price Upside	-0.11%		-0.59%
Technical	Alpha 1Y	-0.59%		+0.58%
Fundamental	Upgrade to unlock			-0.52%
Technical	Upgrade to unlock			-0.45%
Technical	Upgrade to unlock			-0.43%
Technical	Upgrade to unlock			-0.42%
Sentiment	Upgrade to unlock			+0.41%

Rest of Alpha Signals: -0.56%

GDRX probability advantage of beating the market (3M)Total:-10.64%
GDRX AI Score

Significant changes Vs previous day

GDRX Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$3.08
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

GDRX Proven Sell Signal & Price Forecast

This is the price chart for GDRX from January 1, 2026 until today. The chart indicates, in red, the 45 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

GDRX Average Past Performance & Loss Rate

Three months after its 399 Sell signals since June 2026, GDRX had an average performance of xxxxxx and a xxxxxx Loss rate (negative performance).

399 Past GDRX Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-16.66%
Average Alpha				-33.01%
Loss Rate (% Negative Perf.)				69.36%
% Negative Alpha				82.66%

GDRX Past Sell Signals Performance

Performance and alpha after 1, 3, 6 months, and 1 year, for each of the 382 days that GDRX was rated a Strong Sell/Sell (AI Score 1 to 3) since June 2026.

Date	Perf. 1M	Perf. 3M	Perf. 6M	Perf. 1Y	Alpha. 1M	Alpha. 3M	Alpha. 6M	Alpha. 1Y
2021-02-03	-19.79%	-28.74%	-38.29%	-45.83%	-20.25%	-37.62%	-53.25%	-65.60%
2022-02-14				-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-
Showing 1 to 10 of 382 days 1 2 3 4 5 ... 39
-	-	-	-	-	-	-	-	-

Date	AI Score	Perf. 1M	Perf. 3M	Perf. 6M	Perf. 1Y	Alpha. 1M	Alpha. 3M	Alpha. 6M	Alpha. 1Y

GDRX Frequently Asked Questions

Will GoodRx stock go up?
According to Danelfin AI, GoodRx has today an AI Score of 1/10 (Strong Sell rating), because its probability of beating the market in 3 months (40.17%) is -10.64% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for GoodRx stock?
Is it a good time to buy, sell, or hold GoodRx stock right now?
Is GoodRx undervalued right now?
What was the price range of GoodRx stock over the past 12 months?
What is going on with GoodRx stock in the last 3 months?
Does GoodRx offer dividend payments?
What is the current market capitalization of GoodRx?
When is the next GDRX earnings report date?

GoodRx Holdings Inc Company Profile

GoodRx Holdings, Inc., in conjunction with its subsidiary entities, furnishes users with resources and data, enabling price comparisons to aid savings on prescription drug acquisitions within America. Operating a comparison platform designed for prices, the corporation provides consumers with carefully chosen, locally applicable prescription pricing information and bestows access to agreed-upon cost details.

Further extending their product and service range, GoodRx offers an array of additional healthcare provisions. This includes subscription models and solutions tailored for pharmaceutical manufacturers along with telemedicine facilities courtesy of the GoodRx Care platform.

Serving as a vital link between consumers and pharmacies, the company is pivotal for pharmacy benefit managers who govern formularies and manage prescription transactions which also include determining pricing agreements.

The foundations of GoodRx Holdings were laid down in 2011, fast establishing itself as a key player within the health care industry. Today, it operates from its origin city of Santa Monica, California where it maintains its corporate headquarters.

Sector:Health Care
Country:United States
Industry:Health Care Technology
Address:2701 Olympic Boulevard, Santa Monica
Employees:697
Website:investors.goodrx.com

Pros

Two-sided marketplace network effects between users and pharmacies

High switching costs for consumers seeking prescription savings

Proprietary data aggregation for prescription drug pricing

Asset-light business model with low capital expenditure

Addresses structural inefficiencies in prescription drug pricing

Cons

Dependence on pharmacy benefit manager relationships

Exposure to evolving healthcare regulation and data privacy laws

Competition from large healthcare incumbents entering price comparison

Limited pricing power due to core price transparency offering

Risk of disintermediation by pharmacies or PBMs

Pros

Cons

Company

AI Score

Compare

UNHUnitedHealth Group Inc

CVSCVS Health Corp

CAHCardinal Health Inc

MCKMcKesson Corp

OPRXOptimizeRx Corp

Company

AI Score

Compare

GDRX Top 10 Industry Stocks

Health Care Technology

	Company	AI Score	Compare
1	CCLDCareCloud Inc
2	WAYWaystar Holding Corp
3	OPRXOptimizeRx Corp
4	DRIODarioHealth Corp
5	DHDefinitive Healthcare Corp
6	SOPHSOPHiA GENETICS SA
7	DOCSDoximity Inc
8	PHRPhreesia Inc
9	HCATHealth Catalyst Inc
10	SLPSimulations Plus Inc

	Company	AI Score	Compare

GDRX Top 10 Sector Stocks

Health Care

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc
2	IMNMImmunome Inc
3	VRDNViridian Therapeutics Inc
4	ZYMEZymeworks Inc
5	LBRXLB Pharmaceuticals Inc
6	PAHCPhibro Animal Health Corp
7	CGONCG Oncology Inc
8	EBSEmergent BioSolutions Inc
9	ACRVAcrivon Therapeutics Inc
10	RNAAvidity Biosciences Inc

	Company	AI Score	Compare

GDRX Stock AI Analysis